Functional response to cardiac resynchronization therapy is associated with improved clinical outcome and absence of appropriate shocks
- PMID: 23210664
- DOI: 10.1111/jce.12037
Functional response to cardiac resynchronization therapy is associated with improved clinical outcome and absence of appropriate shocks
Abstract
Introduction: We evaluated clinical outcome and incidence of (in)appropriate shocks in consecutive chronic heart failure (CHF) patients treated with CRT with a defibrillator (CRT-D) according to functional response status. Furthermore, we investigated which factors predict such functional response.
Methods and results: In a large teaching hospital, 179 consecutive CHF patients received CRT-D in 2005-2010. Patients were considered functional responders if left ventricular ejection fraction (LVEF) increased to ≥ 35% postimplantation. Analysis was performed on 142 patients, who had CRT-D as primary prevention, complete data and a baseline LVEF <35%. Endpoints consisted of all-cause mortality, heart failure (HF) hospitalizations, appropriate shocks and inappropriate shocks. Median follow-up was 3.0 years (interquartile range [IQR] 1.6-4.4) and median baseline LVEF was 20% (IQR 18-25%). The functional response-group consisted of 42 patients. In this group no patients died, none were hospitalized for HF, none received appropriate shocks and 3 patients (7.1%) received ≥ 1 inappropriate shocks. In comparison, the functional nonresponse group consisted of 100 patients, of whom 22 (22%) died (P = 0.003), 17 (17%) were hospitalized for HF (P = 0.007), 17 (17%) had ≥ 1 appropriate shocks (P = 0.003) and 8 (8.1%) received ≥ 1 inappropriate shocks (P = 0.78). Multivariable analysis showed that left bundle branch block (LBBB), QRS duration ≥ 150 milliseconds and no need for diuretics at baseline are independent predictors of functional response.
Conclusion: Functional responders to CRT have a good prognosis and rarely need ICD therapy. LBBB, QRS duration ≥ 150 milliseconds and lack of chronic diuretic use predict functional response.
© 2012 Wiley Periodicals, Inc.
Similar articles
-
Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.J Cardiovasc Electrophysiol. 2013 Oct;24(10):1116-22. doi: 10.1111/jce.12208. Epub 2013 Jul 25. J Cardiovasc Electrophysiol. 2013. PMID: 23889733
-
QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.J Cardiovasc Electrophysiol. 2013 Apr;24(4):442-8. doi: 10.1111/jce.12057. Epub 2012 Dec 17. J Cardiovasc Electrophysiol. 2013. PMID: 23252875 Clinical Trial.
-
Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.J Am Coll Cardiol. 2012 Jun 19;59(25):2366-73. doi: 10.1016/j.jacc.2012.01.065. J Am Coll Cardiol. 2012. PMID: 22698490 Clinical Trial.
-
The efficacy and safety of cardiac resynchronization therapy combined with implantable cardioverter defibrillator for heart failure: a meta-analysis of 5674 patients.Europace. 2013 Jul;15(7):992-1001. doi: 10.1093/europace/eus419. Epub 2013 Feb 17. Europace. 2013. PMID: 23419662 Review.
-
An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure.Eur Heart J. 2013 Dec;34(46):3547-56. doi: 10.1093/eurheartj/eht290. Epub 2013 Jul 29. Eur Heart J. 2013. PMID: 23900696 Free PMC article. Review.
Cited by
-
Antiarrhythmic Drug Therapy to Avoid Implantable Cardioverter Defibrillator Shocks.Arrhythm Electrophysiol Rev. 2016 Aug;5(2):117-21. doi: 10.15420/AER.2016.10.2. Arrhythm Electrophysiol Rev. 2016. PMID: 27617090 Free PMC article.
-
Elevated B-Type Natriuretic Peptide Level as a Residual Risk Factor for Ventricular Arrhythmias Among Patients Undergoing Cardiac Resynchronization Therapy With Improved Left Ventricular Ejection Fraction.Circ Rep. 2024 Sep 14;6(10):407-414. doi: 10.1253/circrep.CR-24-0065. eCollection 2024 Oct 10. Circ Rep. 2024. PMID: 39391552 Free PMC article.
-
When Is It Safe Not to Reimplant an Implantable Cardioverter Defibrillator at the Time of Battery Depletion?Card Electrophysiol Clin. 2018 Mar;10(1):137-144. doi: 10.1016/j.ccep.2017.11.014. Card Electrophysiol Clin. 2018. PMID: 29428135 Free PMC article. Review.
-
Outcomes in Heart Failure With Improved Ejection Fraction Following Implantable Cardioverter-Defibrillator Placement for Primary Prevention.Cureus. 2025 Jun 4;17(6):e85360. doi: 10.7759/cureus.85360. eCollection 2025 Jun. Cureus. 2025. PMID: 40621223 Free PMC article.
-
Cardiac resynchronization therapy is associated with a reduction in ICD therapies as it improves ventricular function.Clin Cardiol. 2018 Jun;41(6):803-808. doi: 10.1002/clc.22958. Epub 2018 Jun 5. Clin Cardiol. 2018. PMID: 29604094 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous